The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection.
Open accessAbstract
The cultured T-cell line TIL1200, established from the tumor-infiltrating lymphocytes (TILs) of a patient with advanced metastatic melanoma, recognized an antigen on most HLA-A2+ melanomas and on all HLA-A2+ cultured neonatal melanocytes in an HLA-A2 restricted manner but not on other types of tissues or cell lines tested. A cDNA encoding an antigen recognized by TIL1200 was isolated by screening an HLA-A2+ breast cancer cell line transfected with an expression cDNA library prepared from an HLA-A2+ melanoma cell line. The nucleotide and amino acid sequences of this cDNA were almost identical to the genes encoding glycoprotein gp100 or Pmel17 previously registered in the GenBank. Expression of this gene was restricted to melanoma and melanocyte cell lines and retina but was not expressed on other fresh or cultured normal tissues or other types of tumor tested. The cell line transfected with this cDNA also expressed antigen recognized by the melanoma-specific antibody HMB45 that bound to gp100. A synthetic 10-amino acid peptide derived from gp100 was recognized by TIL1200 in the context of HLA-A2.1. Since the administration of TIL1200 plus interleukin 2 resulted in regression of metastatic cancer in the autologous patient, gp100 is a possible tumor rejection antigen and may be useful for the development of immunotherapies for patients with melanoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., & Boon, T. (1991) · Science · doi:10.1126/science.1840703 · Cited by 3,545
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
Falk, K., Rötzschke, O., Stevanovié, S., Jung, G., & Rammensee, H.-G. (1991) · Nature · doi:10.1038/351290a0 · Cited by 2,411
Rosenberg, S. A., Packard, B. S., Aebersold, P. M., Solomon, D., Topalian, S. L., Toy, S. T., Simon, P., Lotze, M. T., Yang, J. C., Seipp, C. A., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812223192527 · Cited by 2,389
Self-citationCharacterization of Peptides Bound to the Class I MHC Molecule HLA-A2.1 by Mass Spectrometry
Hunt, D. F., Henderson, R. A., Shabanowitz, J., Sakaguchi, K., Michel, H., Sevilir, N., Cox, A. L., Appella, E., & Engelhard, V. H. (1992) · Science · doi:10.1126/science.1546328 · Cited by 1,198
Self-citationKawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Rivoltini, L., Topalian, S. L., Miki, T., & Rosenberg, S. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3515 · Cited by 1,092
Self-citationBrichard, V, Van Pel, A., Wölfel, T., Wölfel, C., De Plaen, E., Lethé, B., Coulie, P., & Boon, T. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.2.489 · Cited by 950
Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules
Ruppert, J., Sidney, J., Celis, E., Kubo, R. T., Grey, H. M., & Sette, A. (1993) · Cell · doi:10.1016/0092-8674(93)90472-3 · Cited by 628
Bakker, A. B., Schreurs, M. W., de Boer, A. J., Kawakami, Y., Rosenberg, S. A., Adema, G. J., & Figdor, C. G. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.3.1005 · Cited by 589
Self-citationMonoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes.
Gown, A. M., VOGEL, A. M., Hoak, D., Gough, F., & McNutt, M. A. (1986) · PubMed Central · Cited by 536
Vitiligo in patients with metastatic melanoma: A good prognostic sign
Nordlund, J. J., Kirkwood, J. M., Forget, B. M., Milton, G., Albert, D. M., & Lerner, A. B. (1983) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(83)70182-9 · Cited by 288
Sequential chemoimmunotherapy in the treatment of metastatic melanoma.
Richards, J. M., Mehta, N., Ramming, K., & Skosey, P. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.8.1338 · Cited by 257
Pockaj, B. A., Sherry, R. M., Wei, J. P., Yannelli, J. R., Carter, C. S., Leitman, S. F., Carasquillo, J. A., Steinberg, S. M., Rosenberg, S. A., & Yang, J. C. (1994) · Cancer · doi:10.1002/1097-0142(19940315)73:6<1731::aid-cncr2820730630>3.0.co;2-h · Cited by 199
Self-citationPrognostic Significance of Hypopigmentation in Malignant Melanoma
Bystryn, J.-C. (1987) · Archives of Dermatology · doi:10.1001/archderm.1987.01660320095019 · Cited by 171
Kwon, B. S., Chintamaneni, C. D., Kozak, C. A., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Barton, D. E., Francke, U., Kobayashi, Y. M., & Kim, K. K. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.20.9228 · Cited by 166
Kawakami, Y., Rosenberg, S. A., & Lotze, M. T. (1988) · The Journal of experimental medicine · doi:10.1084/jem.168.6.2183 · Cited by 160
Self-citationDevelopment of a highly efficient expression cDNA cloning system: application to oncogene isolation.
Miki, T., Fleming, T. P., Crescenzi, M., Molloy, C. J., Blam, S. B., Reynolds, S. H., & Aaronson, S. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5167 · Cited by 142
Self-citationA monoclonal antibody specific for cells of the melanocyte lineage.
Vennegoor, C., Hageman, P., Nouhuijs, H. M. P.-V., Ruiter, D. J., Calafat, J., Ringens, P. J., & Rümke, P. (1988) · Europe PMC (PubMed Central) · Cited by 140
Adema, G. J., de Boer, A. J., Hullenaar, R. V., Denijn, M., Ruiter, D. J., VOGEL, A. M., & Figdor, C. G. (1993) · PubMed Central · Cited by 102
Self-citationUltrastructural localization of HMB‐45 binding sites
Schaumburg‐Lever, G., Metzler, G., & KAISERLING, E. (1991) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.1991.tb01380.x · Cited by 73
T-Cell Recognition of Human Melanoma Antigens
Kawakami, Y., Nishimura, M. I., Restifo, N. P., Topalian, S. L., O’Neil, B. H., Shilyansky, J., Yannelli, J. R., & Rosenberg, S. A. (1993) · Journal of Immunotherapy · doi:10.1097/00002371-199308000-00002 · Cited by 70
Self-citationComplete Sequence and Expression of a cDNA Encoding a Chicken 115‐kDa Melanosomal Matrix Protein
Mochii, M., Agata, K., & Eguchi, G. (1991) · Pigment Cell Research · doi:10.1111/j.1600-0749.1991.tb00312.x · Cited by 67
Shilyansky, J., Nishimura, M. I., Yannelli, J. R., Kawakami, Y., Jacknin, L., Charmley, P., & Rosenberg, S. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.7.2829 · Cited by 65
Self-citationZakut, R., Topalian, S. L., Kawakami, Y., Mancini, M., Eliyahu, S., & Rosenberg, S. A. (1993) · PubMed · Cited by 62
Self-citationVOGEL, A. M., & Esclamado, R. M. (1988) · PubMed · Cited by 28
Kim, R. Y., & Wistow, G. J. (1992) · Experimental Eye Research · doi:10.1016/0014-4835(92)90170-w · Cited by 22
Cited by
Zhang, Y., & Zhang, Z. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0488-6 · Cited by 2,794
Adoptive cell transfer as personalized immunotherapy for human cancer
Rosenberg, S. A., & Restifo, N. P. (2015) · Science · doi:10.1126/science.aaa4967 · Cited by 2,506
Self-citationRosenberg, S. A., Yang, J. C., Schwartzentruber, D. J., Hwu, P., Marincola, F. M., Topalian, S. L., Restifo, N. P., Dudley, M. E., Schwarz, S. L., Spiess, P. J., et al. (1998) · Nature Medicine · doi:10.1038/nm0398-321 · Cited by 1,784
Self-citationMHC ligands and peptide motifs: first listing
Rammensee, H.-G., Friede, T., & Stevanović, S. (1995) · Immunogenetics · doi:10.1007/bf00172063 · Cited by 1,638
Johnson, L. A., Morgan, R. A., Dudley, M. E., Cassard, L., Yang, J. C., Hughes, M. S., Kammula, U. S., Royal, R. E., Sherry, R. M., Wunderlich, J. R., et al. (2009) · Blood · doi:10.1182/blood-2009-03-211714 · Cited by 1,418
Self-citation
Metadata
- Authors
- Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Sakaguchi, K., Appella, E., Yannelli, J. R., Adema, G. J., Miki, T., & Rosenberg, S. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1994-07-05
- Volume
- 91
- Issue
- 14
- Pages
- 6458-6462
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1986046751
- Cited by
- 914
- References
- 25
- FWCI
- 27.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.